Cargando…
An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model
Alzheimer’s disease (AD) is the most common form of dementia, but there is still no available treatment. Δ9-tetrahydrocannabinol (THC) is emerging as a promising therapeutic agent. Using THC in conventional high doses may have deleterious effects. Therefore, we propose to use an ultra-low dose of TH...
Autores principales: | Nitzan, Keren, Ellenbogen, Leah, Bentulila, Ziv, David, Dekel, Franko, Motty, Break, Emanuela P., Zoharetz, Michal, Shamir, Alon, Sarne, Yosef, Doron, Ravid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408848/ https://www.ncbi.nlm.nih.gov/pubmed/36012711 http://dx.doi.org/10.3390/ijms23169449 |
Ejemplares similares
-
Anxiolytic and antidepressants’ effect of Crataegus pinnatifida (Shan Zha): biochemical mechanisms
por: Nitzan, Keren, et al.
Publicado: (2022) -
Moderation of the transgenerational transference of antenatal stress-induced anxiety
por: Burstein, Or, et al.
Publicado: (2021) -
Editorial: The burden of stress and depression – new insight into faster and efficient treatment
por: Nitzan, Keren, et al.
Publicado: (2022) -
Escitalopram or Novel Herbal Mixture Treatments during or following Exposure to Stress Reduce Anxiety-Like Behavior through Corticosterone and BDNF Modifications
por: Doron, Ravid, et al.
Publicado: (2014) -
Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression
por: Burstein, Or, et al.
Publicado: (2017)